These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1970411)

  • 1. Ototoxicity associated with dideoxycytidine.
    Powderly WG; Klebert MK; Clifford DB
    Lancet; 1990 May; 335(8697):1106. PubMed ID: 1970411
    [No Abstract]   [Full Text] [Related]  

  • 2. Acoustic neuropathy associated with zalcitabine-induced peripheral neuropathy.
    Martinez OP; French MA
    AIDS; 1993 Jun; 7(6):901-2. PubMed ID: 8395858
    [No Abstract]   [Full Text] [Related]  

  • 3. [New, in Austria registered specialty drugs. Hivid (2',3'-dideoxycytidine; ddC)].
    Töglhofer W
    Wien Klin Wochenschr; 1992; 104(12):363-7. PubMed ID: 1353278
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC).
    Dubinsky RM; Yarchoan R; Dalakas M; Broder S
    Muscle Nerve; 1989 Oct; 12(10):856-60. PubMed ID: 2558314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment IND for dideoxycytidine.
    Am Fam Physician; 1991 Sep; 44(3):1051. PubMed ID: 1652191
    [No Abstract]   [Full Text] [Related]  

  • 6. Ototoxicity associated with a once daily dose amikacin regimen in febrile neutropenic patients.
    Kibbler CC; McWhinney PH; Warner P; Prentice HG
    J Antimicrob Chemother; 1992 Apr; 29(4):463-4. PubMed ID: 1607336
    [No Abstract]   [Full Text] [Related]  

  • 7. Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity. A case report.
    Ress BD; Gross EM
    Ann Otol Rhinol Laryngol; 2000 Apr; 109(4):435-7. PubMed ID: 10778901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ototoxicity of high-dose carboplatin.
    Chevreau C; Thomas F; Couteau C; Dalenc F; Mourey L; Chatelut E
    J Clin Oncol; 2005 May; 23(15):3649-50; author reply 3650-1. PubMed ID: 15908692
    [No Abstract]   [Full Text] [Related]  

  • 9. Dermatologic complications associated with administration of 2',3'-dideoxycytidine in patients with human immunodeficiency virus infection.
    McNeely MC; Yarchoan R; Broder S; Lawley TJ
    J Am Acad Dermatol; 1989 Dec; 21(6):1213-7. PubMed ID: 2555402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.
    Ekborn A; Hansson J; Ehrsson H; Eksborg S; Wallin I; Wagenius G; Laurell G
    Laryngoscope; 2004 Sep; 114(9):1660-7. PubMed ID: 15475801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infection.
    Nguyen BY; Shay LE; Wyvill KM; Pluda JM; Brawley O; Cohen RB; Whitcup SM; Venzon DJ; Broder S; Yarchoan R
    J Infect Dis; 1993 Oct; 168(4):810-7. PubMed ID: 8397267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ototoxicity of ear drops: a clinical perspective.
    Linder TE; Zwicky S; Brändle P
    Am J Otol; 1995 Sep; 16(5):653-7. PubMed ID: 8588672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of edaravone against tobramycin-induced ototoxicity.
    Asplund MS; Lidian A; Linder B; Takumida M; Anniko M
    Acta Otolaryngol; 2009 Jan; 129(1):8-13. PubMed ID: 18607936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycoside ototoxicity: a human temporal bone study.
    Hinojosa R; Nelson EG; Lerner SA; Redleaf MI; Schramm DR
    Laryngoscope; 2001 Oct; 111(10):1797-805. PubMed ID: 11801948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of the ototoxicity of cisplatin].
    Basterra J; Iranzo C; Marco J
    An Otorrinolaringol Ibero Am; 1985; 12(2):167-72. PubMed ID: 4039901
    [No Abstract]   [Full Text] [Related]  

  • 16. Expanded access for AIDS drug.
    Iowa Med; 1991 Mar; 81(3):129. PubMed ID: 1851497
    [No Abstract]   [Full Text] [Related]  

  • 17. Sensorineural hearing loss following imatinib (Gleevec) administration.
    Lin HW; Roberts DS; Kay J; Stankovic KM
    Otolaryngol Head Neck Surg; 2012 Feb; 146(2):335-7. PubMed ID: 21753034
    [No Abstract]   [Full Text] [Related]  

  • 18. Pancreatitis possibly related to 2'-3'-dideoxycytidine.
    Aponte-Cipriani SL; Teplitz C; Yancovitz S
    Ann Intern Med; 1993 Sep; 119(6):539-40. PubMed ID: 8395145
    [No Abstract]   [Full Text] [Related]  

  • 19. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
    Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
    Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chloramphenicol ototoxicity. A case report.
    Iqbal SM; Srivatsav CB
    J Laryngol Otol; 1984 May; 98(5):523-5. PubMed ID: 6715985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.